Join Now

Author Archives: Denise Bell

Reddyport’s New Non-Invasive Ventilation Products to Allow Patient Communication/Oral Care is Funded Through Launch

By Denise Bell | Published December 23, 2020

ReddyPort has announced it has raised Seed Funding to support launch of its non-invasive ventilation (NIV) products in 2021. Tony Lair, the former CEO of NeoMed (acquired by Avanos), led the investment round with participation from existing and new investors, including Spring Bay Ventures and MedMountain Ventures. Tony Lair will join ReddyPort’s Board of Directors. […]

Posted in Policy News | Leave a comment

Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test

By Denise Bell | Published December 23, 2020

Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers and is able to meet high demand. The test has recently received FDA emergency use authorization. “We are thrilled to have a point of care rapid antibody test now available. We know hospitals, medical offices, and other […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark

By Denise Bell | Published December 23, 2020

ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The test kit was developed to distinguish SARS-CoV-2 from other respiratory viruses, including influenza A/B and respiratory syncytial virus types A/B that may have similar symptoms. It runs on the firm’s Elite InGenius platform, as well as other […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

Congress Passes $900 Billion COVID Stimulus Package While Trump Calls for $2,000 in Direct Payments

By Denise Bell | Published December 23, 2020

Both the House of Representatives and the Senate passed on Monday a more than $900 billion COVID-19 stimulus package. The long-awaited and much needed assistance comes after months of protracted wrangling between the parties. As of this writing, President Trump did not say he would veto the bill but he asked Congress to amend it […]

Posted in Policy News | Leave a comment

Congress Nears Deal on COVID-19 Stimulus Package

By Denise Bell | Published December 18, 2020

Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would include more funding for PPP loans, allow a second loan draw for hard-hit small businesses and streamline forgiveness for loans of $150,000 or less. In addition, the measure is expected to include some level of direct payments […]

Posted in COVID-19 Legislation, COVID-19 Updates, Policy News | Leave a comment

SDP Oncology Presents Data Evaluating Alvocidib in Patients with Acute Myeloid Leukemia and Other Updates on Development Programs at ASH 2020

By Denise Bell | Published December 11, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]

Posted in BioUtah News | Leave a comment

Utah Readies to Receive 154,000 COVID-19 Vaccines

By Denise Bell | Published December 11, 2020

Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19 vaccine. In addition to teachers, the first phase of vaccinations in Utah will focus on healthcare workers, as well as residents and staff of long-term care facilities. Last week, BioUtah sent a letter to the Utah Department […]

Posted in COVID-19 Updates, Feature, State News | Leave a comment

Drug Industry Trade Groups File Lawsuits on Most-Favored-Nation Pricing Rule

By Denise Bell | Published December 11, 2020

The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]

Posted in Policy News | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

By Denise Bell | Published December 4, 2020

Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]

Posted in BioUtah News, Life Sciences Industry News, Press Releases, Utah's Life Sciences Companies | Leave a comment

Utah COVID-19 Small Business Quarantined Employee Grants

By Denise Bell | Published December 4, 2020

Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee Grant program. If an employee needs to quarantine or isolate due to a COVID-19 exposure or positive test, employers can continue paying them and be reimbursed with this grant program. Utah created this program to reimburse small […]

Posted in BioUtah News, COVID-19 Updates, State News | Leave a comment

Braveheart Brings Healthcare to India’s Last Mile Community

By Denise Bell | Published December 4, 2020

These days we can all use uplifting news, so please check out this short story about how BraveHeart technology is harnessing AI to bridge India’s healthcare divide. iKures, an Indian healthcare company, is equipping community workers in remote areas of the country with BraveHeart portable devices to measure blood pressure, hemoglobin levels, or heart rates […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

Who’s First In Line for the COVID Vaccine? CDC’s Immunization Advisory Committee Makes Recommendations

By Denise Bell | Published December 4, 2020

With the first shipments of the Pfizer/BioNTech vaccine scheduled to arrive in a matter of weeks and Moderna doses soon after, a big question looms: who gets them first? Independent health policy experts on the vaccine advisory committee to the Centers for Disease Control and Prevention (CDC) met this week to make a recommendation. The CDC Advisory Committee on […]

Posted in COVID-19 Updates, Life Sciences Industry News, Policy News | Leave a comment

A Special Thanks To Our Elite Members